Dr. Mario E. Lacouture, MD

Dr. Lacouture practices at NYU Faculty Group Practice in Mineola, New York.

Dr. Lacouture's NPI, 1679563324, was assigned on October 25, 2005. Dr. Lacouture graduated from Pontifical Xavierian University in 1997. Dr. Lacouture holds New York license 254307.

Dr. Lacouture's primary practice is NYU Faculty Group Practice, at 120 Mineola Blvd, Mineola, NY 11501 in Nassau County. The practice phone is (877) 648-2964.

Dr. Lacouture's primary practice is NYU Faculty Group Practice in Mineola, New York. Dr. Lacouture is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Lacouture to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lacouture practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lacouture's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Lacouture's licenses on file in 2 states: New York and Illinois.

CMS data shows 1,844 Medicare services from Dr. Lacouture across 21 procedure codes in 2024, for 590 Medicare patients. Medicare paid $164,914 for them. Every service was in an office.

CMS counts 590 Medicare patients who saw Dr. Lacouture in 2024. The largest group is 65 to 74, with 260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lacouture's median patient age at 60, with 62% women.

In 2024, Dr. Lacouture wrote 2,619 Medicare Part D claims for 634 patients. 82% of them were for generic drugs. CMS names the drug for 2,430 of them, across 41 drugs with 11 or more claims each, at $888,294 in total drug cost. In 2023, CMS named 1,528 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lacouture for performance year 2024, reported as part of a group. Dr. Lacouture accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lacouture as offering telehealth. CMS counts 309 procedures of skin biopsy by Dr. Lacouture, more than 91% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Lacouture to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Gastrointestinal Stromal Tumors and Neoplasms, Connective Tissue. Open Payments lists research payments to Dr. Lacouture that name 2 trials.

CMS Open Payments shows 180 general payments to Dr. Lacouture from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Novartis Pharmaceuticals Corporation paid the most, $46,476. It also lists 21 research payments totaling $169,061 from 2017 to 2023, naming 2 clinical trials.

Dr. Lacouture graduated from Pontifical Xavierian University in 1997.